What is it about?
skin malignancy can be due to prolonged usage of immunosuppressive therapy
Featured Image
Why is it important?
We emphasise the possibility of developing skin malignancy in a patient with prolonged immunosuppressive therapy.
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had a short collaborations. This article also lead to rare disease groups contacting me and ultimately to a greater involvement in rare disease research.
Hanida Hanafi
Read the Original
This page is a summary of: Eyelid Merkel cell carcinoma in a patient treated with golimumab, Orbit, August 2017, Taylor & Francis,
DOI: 10.1080/01676830.2017.1353118.
You can read the full text:
Contributors
The following have contributed to this page
